Popular stocks:

GameStop

Zomedica

Churchill Capital Corp IV

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: January 29, 2023 12:51

Allogene Therapeutics stock price online today

Analyst Target Price

22.53

Dividend Date

Ex Dividend Date

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2022, 2024, 2025?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $22.53 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (10.33 $).

50 Day Moving Average is the resistance level (7.95 $).

Allogene Therapeutics stock monthly Forecast

Date	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
31 Jan 23	9.80	9.44	10.04	6.40 %
01 Feb 23	9.70	9.29	9.94	7.01 %
02 Feb 23	9.34	8.85	9.69	9.46 %
03 Feb 23	9.03	8.87	9.49	7.06 %
04 Feb 23	9.62	9.15	9.89	8.10 %
05 Feb 23	9.81	9.47	10.31	8.92 %
06 Feb 23	10.04	9.80	10.60	8.10 %
07 Feb 23	10.27	10.12	10.45	3.27 %
08 Feb 23	10.94	10.66	11.14	4.52 %
09 Feb 23	11.04	10.80	11.37	5.29 %
10 Feb 23	11.13	10.50	11.43	8.82 %
11 Feb 23	11.51	10.92	12.07	10.48 %
12 Feb 23	11.26	10.78	11.62	7.82 %
13 Feb 23	11.73	11.23	12.00	6.87 %
14 Feb 23	12.17	11.73	12.83	9.44 %
15 Feb 23	11.96	11.56	12.51	8.18 %
16 Feb 23	12.43	11.88	12.88	8.43 %
17 Feb 23	13.15	12.78	13.50	5.62 %
18 Feb 23	12.55	11.90	13.02	9.45 %
19 Feb 23	12.40	11.70	13.01	11.12 %
20 Feb 23	12.28	11.98	12.92	7.89 %
21 Feb 23	12.03	11.43	12.61	10.31 %
22 Feb 23	12.34	11.99	12.58	4.90 %
23 Feb 23	12.88	12.69	13.34	5.11 %
24 Feb 23	13.55	13.31	13.82	3.78 %
25 Feb 23	13.08	12.72	13.33	4.82 %
26 Feb 23	13.05	12.82	13.52	5.49 %
27 Feb 23	12.30	11.71	12.71	8.61 %
28 Feb 23	11.76	11.59	12.26	5.75 %
01 Mar 23	11.85	11.65	12.44	6.76 %

ALLO daily forecast for this month

Allogene Therapeutics stock forecast for 31.01.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.80 Positive intraday dynamics of the instrument is expected with 6.013% volatility is expected.

Pessimistic forecast: 9.44

Optimistic: 10.04

Allogene Therapeutics stock forecast for 01.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.70 Negative intraday dynamics of the instrument is expected with 6.555% volatility is expected.

Pessimistic forecast: 9.29

Optimistic: 9.94

Allogene Therapeutics stock forecast for 02.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.34 Negative intraday dynamics of the instrument is expected with 8.639% volatility is expected.

Pessimistic forecast: 8.85

Optimistic: 9.69

Allogene Therapeutics stock forecast for 03.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.03 Negative intraday dynamics of the instrument is expected with 6.593% volatility is expected.

Pessimistic forecast: 8.87

Optimistic: 9.49

Allogene Therapeutics stock forecast for 04.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.62 Positive intraday dynamics of the instrument is expected with 7.490% volatility is expected.

Pessimistic forecast: 9.15

Optimistic: 9.89

ALLO Forecast for 2023

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Feb	9.66	8.98	10.05	10.66 %
Mar	9.86	9.21	10.26	10.28 %
Apr	9.90	9.50	10.60	10.36 %
May	9.66	9.36	10.36	9.61 %
Jun	9.53	9.32	9.73	4.21 %
Jul	9.36	8.98	9.72	7.60 %
Aug	9.14	8.67	9.84	11.88 %
Sep	8.98	8.60	9.43	8.86 %
Oct	8.91	8.63	9.56	9.79 %
Nov	9.56	8.96	9.94	9.82 %
Dec	9.16	8.45	9.49	11.00 %

Detailed forecast for 2023

Allogene Therapeutics stock forecast for this year

Allogene Therapeutics share price average forecast for Feb 2023 is: 9.65756 The dynamics are positive.
Allogene Therapeutics share price average forecast for Mar 2023 is: 9.86037 The dynamics are positive.
Allogene Therapeutics share price average forecast for Apr 2023 is: 9.89981 The dynamics are positive.
Allogene Therapeutics share price average forecast for May 2023 is: 9.66222 The dynamics are negative.
Allogene Therapeutics share price average forecast for Jun 2023 is: 9.52694 The dynamics are negative.
Allogene Therapeutics share price average forecast for Jul 2023 is: 9.35546 The dynamics are negative.
Allogene Therapeutics share price average forecast for Aug 2023 is: 9.14028 The dynamics are negative.
Allogene Therapeutics share price average forecast for Sep 2023 is: 8.9849 The dynamics are negative.
Allogene Therapeutics share price average forecast for Oct 2023 is: 8.91302 The dynamics are negative.
Allogene Therapeutics share price average forecast for Nov 2023 is: 9.56367 The dynamics are positive.
Allogene Therapeutics share price average forecast for Dec 2023 is: 9.162 The dynamics are negative.

Allogene Therapeutics stock Forecast for 2024

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	9.46	9.09	9.68	6.16 %
Feb	9.13	8.41	9.43	10.84 %
Mar	9.82	9.62	10.60	9.26 %
Apr	9.72	9.07	10.47	13.37 %
May	9.37	9.09	9.56	4.90 %
Jun	9.34	9.11	9.93	8.28 %
Jul	10.20	9.75	10.92	10.65 %
Aug	10.17	9.91	10.80	8.29 %
Sep	10.56	9.87	11.14	11.37 %
Oct	10.41	9.84	10.71	8.16 %
Nov	10.61	10.30	11.33	9.08 %
Dec	10.62	9.85	10.99	10.34 %

Detailed forecast for 2024

Allogene Therapeutics stock Forecast for 2025

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	10.24	9.63	10.90	11.64 %
Feb	11.02	10.35	11.48	9.80 %
Mar	11.97	11.23	12.85	12.58 %
Apr	13.14	12.09	13.92	13.13 %
May	12.55	11.81	12.85	8.11 %
Jun	12.24	11.40	13.05	12.66 %
Jul	12.61	11.67	13.04	10.44 %
Aug	11.41	10.92	12.05	9.38 %
Sep	11.47	10.85	12.26	11.51 %
Oct	11.48	10.80	12.17	11.23 %
Nov	11.65	10.93	12.55	12.91 %
Dec	12.44	11.76	13.42	12.42 %

Detailed forecast for 2025

Allogene Therapeutics stock Forecast for 2026

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	12.50	12.00	12.75	5.88 %
Feb	12.53	12.02	13.43	10.54 %
Mar	13.31	12.89	13.83	6.74 %
Apr	14.25	13.24	15.02	11.86 %
May	13.25	12.66	13.52	6.37 %
Jun	13.19	12.15	13.56	10.41 %
Jul	13.85	12.88	14.16	9.09 %
Aug	13.56	13.24	14.18	6.60 %
Sep	13.30	12.34	13.62	9.37 %
Oct	13.10	12.31	13.36	7.84 %
Nov	14.24	13.53	15.25	11.30 %
Dec	13.97	13.26	14.67	9.62 %

Detailed forecast for 2026

Allogene Therapeutics stock Forecast for 2027

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	14.37	13.61	15.38	11.50 %
Feb	14.49	13.36	15.14	11.77 %
Mar	14.14	13.69	15.10	9.36 %
Apr	15.43	14.62	15.95	8.32 %
May	15.86	14.76	16.86	12.42 %
Jun	15.89	15.45	16.92	8.73 %
Jul	14.52	13.67	15.25	10.38 %
Aug	13.96	13.47	14.36	6.22 %
Sep	13.83	13.33	14.88	10.41 %
Oct	13.89	13.54	14.58	7.14 %
Nov	15.11	14.28	15.83	9.83 %
Dec	16.36	15.35	17.07	10.07 %

Detailed forecast for 2027

Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

944 576 000 $

EBITDA

-297 499 008

PE Ratio

None

PEG Ratio

None

Dividend Per Share

Dividend Yield

EPS

-2.2

Quarterly Earnings Growth YOY

Quarterly Revenue Growth YOY

Trailing PE

Forward PE

EV To Revenue

2674.75

EV To EBITDA

-2.221

52 Week High

17.49

52 Week Low

5.41

50 Day Moving Average

7.95

200 Day Moving Average

10.33

Shares Outstanding

144210000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Other Healthcare sector assets

Name	Symbol	Last Close Price	Change
Abbott Laboratories	ABT	98.07 (04.11.2022)	1.68 %
AbbVie Inc.	ABBV	145.28 (04.11.2022)	0.60 %
Aeterna Zentaris Inc.	AEZS	4.01 (04.11.2022)	2.82 %
Allakos Inc.	ALLK	5.99 (04.11.2022)	5.83 %
Allogene Therapeutics, Inc.	ALLO	9.34 (04.11.2022)	-1.89 %
Amgen Inc.	AMGN	269.04 (04.11.2022)	1.19 %
Aphria Inc.	APHA	15.38 (07.05.2021)	0.00 %
Atara Biotherapeutics, Inc.	ATRA	4.75 (04.11.2022)	2.15 %
Aurora Cannabis Inc.	ACB	1.31 (04.11.2022)	-5.07 %
Becton Dickinson and Company	BDX	220.84 (04.11.2022)	-0.07 %
Biogen Inc.	BIIB	281.82 (04.11.2022)	0.56 %
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	15.47 (04.11.2022)	4.60 %
BioNTech SE	BNTX	154.31 (04.11.2022)	6.24 %
bluebird bio, Inc.	BLUE	6.13 (04.11.2022)	-2.23 %
Boston Scientific Corp.	BSX	41.59 (04.11.2022)	0.14 %
Bristol-Myers Squibb Company	BMY	78.78 (04.11.2022)	0.38 %
Canopy Growth Corp.	CGC	3.29 (04.11.2022)	-4.64 %
Castle Biosciences, Inc.	CSTL	21.94 (04.11.2022)	-9.60 %
CLOVER HEALTH INVESTMENTS, CORP	CLOV	3.16 (07.01.2022)	-5.67 %
Eli Lilly and Company	LLY	242.27 (04.02.2022)	0.00 %
Emergent BioSolutions Inc.	EBS	19.96 (04.11.2022)	2.20 %
Exelixis, Inc.	EXEL	18.56 (17.06.2022)	5.63 %
G1 Therapeutics, Inc.	GTHX	8.32 (04.11.2022)	4.92 %
Gilead Sciences, Inc.	GILD	80.34 (04.11.2022)	1.11 %
GlaxoSmithKline plc	GSK	32.99 (04.11.2022)	0.46 %
GoodRx Holdings, Inc.	GDRX	5.06 (04.11.2022)	3.27 %
GW Pharmaceuticals plc.	GWPH	218.96 (05.05.2021)	0.00 %
Incyte Corp.	INCY	77.3 (04.11.2022)	0.52 %
Inovio Pharmaceuticals, Inc.	INO	2.11 (04.11.2022)	-1.40 %
Johnson & Johnson	JNJ	171.48 (04.11.2022)	0.45 %
Medtronic plc.	MDT	84.65 (04.11.2022)	0.75 %
Merck & Co., Inc.	MRK	99.2 (04.11.2022)	0.46 %
Moderna, Inc.	MRNA	158.41 (04.11.2022)	7.40 %
Novartis AG	NVS	81.72 (04.11.2022)	1.67 %
Novavax, Inc.	NVAX	19.4 (04.11.2022)	-3.82 %
ObsEva SA	OBSV	0.1688 (04.11.2022)	0.60 %
OrganiGram Holdings Inc.	OGI	0.9738 (04.11.2022)	0.11 %
Pfizer Inc.	PFE	47.22 (04.11.2022)	1.40 %
Regeneron Pharmaceuticals, Inc.	REGN	740.21 (04.11.2022)	0.21 %
Sanofi	SNY	43.62 (04.11.2022)	1.82 %
Schrodinger, Inc.	SDGR	20.92 (04.11.2022)	-15.17 %
Senseonics Holdings, Inc.	SENS	1.18 (04.11.2022)	-0.84 %
Sorrento Therapeutics, Inc.	SRNE	1.46 (04.11.2022)	-1.35 %
Stryker Corp.	SYK	210.98 (04.11.2022)	2.66 %
Sundial Growers Inc.	SNDL	2.32 (04.11.2022)	-2.52 %
Teva Pharmaceutical Industries Lim. (TEVA)	TEVA	8.47 (04.11.2022)	-1.63 %
Thermo Fisher Scientific Inc.	TMO	495.55 (04.11.2022)	1.77 %
Tilray, Inc.	TLRY	3.81 (04.11.2022)	-0.26 %
UnitedHealth Group, Inc.	UNH	538.17 (04.11.2022)	-1.00 %
Veeva Systems Inc.	VEEV	166.81 (04.11.2022)	-0.20 %
Zomedica Corp.	ZOM	0.2245 (04.11.2022)	-2.01 %
Zynerba Pharmaceuticals, Inc.	ZYNE	0.7051 (04.11.2022)	-2.07 %

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.